Stock Price Forecast

Jan. 9, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AIkido Pharma Inc chart...

About the Company

AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.

CEO

Anthony Hayes

Exchange

NASDAQ

Website

aikidopharma.com

$0M

Total Revenue

5

Employees

$18M

Market Capitalization

-1.49

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AIKI News

AIkido Pharma Inc. (AIKI)

2y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)

1mon ago, source: Yahoo

NEW YORK, Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (the "Company") today announced that it has changed its name from AIkido Pharma Inc. to Dominari Holdings Inc. and its ...

Dominari Holdings Provides Update on Share Repurchase Program

21h ago, source:

Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today provided an update on the $2 million share repurchase program (the "Share Repurchase Program") authorized by the Company's ...

Kokikai Aikido

8y ago, source: Princeton University

An effective form of self-defense, Kokikai Aikido relies on a strong mind and correct technique not physical strength alone. As a result classes include both men and women practicing on equal footing.

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)

1mon ago, source: Benzinga.com

NEW YORK, Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. AIKI (the "Company") today announced that it has changed its name from AIkido Pharma Inc. to Dominari Holdings Inc. and its ticker ...

AIkido Pharma Inc. Common Stock (AIKI)

2y ago, source: Nasdaq

Nasdaq provides press releases highlighting valuable information sent out by companies. Here you can find the company’s latest financial figures, contact information, and source version of the ...

Dominari Holdings Provides Update on Share Repurchase Program

1mon ago, source: Benzinga.com

About Dominari Holdings Inc. Dominari Holdings Inc. (f/k/a AIkido Pharma Inc.) until recently was focused primarily on the development of a diverse portfolio of small-molecule anticancer and ...

Aikido Pharma Announces Name And Stocker Ticker Symbol Change To Dominari Holdings Inc. (Nasdaq: DOMH)'

1mon ago, source: Mena FN

AIkido Pharma Inc. (NASDAQ: aiki ) (the 'Company') today announced that it has changed its name from AIkido Pharma Inc. to Dominari Holdings Inc. and its ticker symbol from 'AIKI' to 'DOMH.' ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...